A nationwide study says the HPV vaccine is safe, Finns’ appetites for quick loans grow, and restroom request cards offer relief for IBD sufferers.
A large nation-wide study on the safety of the human papillomavirus vaccine finds no causal link between reported adverse drug reactions and symptoms following the jab, reports national daily Helsingin Sanomat, citing a study in the medical journal Vaccine .
Cervical cancer can be prevented by a human papillomavirus vaccine, which has been part of Finland’s national immunisation programme since 2013. The vaccination is available for 11-12-year-old girls.
Finland’s National Institute for Health and Welfare is currently looking into also providing the injection for boys through the national immunisation programme. This summer a Tampere University study found that a 45 percent immunisation rate in girls and 20 percent in boys would establish herd immunity against a range of cancers linked to the human papillomavirus.